Introduction
The US Food and Drug Administration (FDA) approved 2 new labeling changes to include information on pediatric use -- Corlopam (fenoldopam mesylate) injection and Zemplar (paricalcitol) injection.
Ketek (telithromycin) tablets, a new ketolide class of anti-infectives, received FDA approval for the treatment of community-acquired pneumonia (CAP), acute bacterial exacerbation of chronic bronchitis (ABECB), and acute bacterial sinusitis (ABS).
This month's column reviews FDA new product approvals and labeling changes for:
Antihypertensive Agents
|
Anti-infective Agents
|
Antipsychotic Agents
|
Insulins
|
Respiratory Agents
|
Urologic Agents
|
Vitamin D
|
Medscape Pharmacists. 2004;5(1) © 2004 Medscape
Cite this: May 2004 - Medscape - Jun 04, 2004.
